| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |